Registered entities
Brooklyn ImmunoTherapeutics, Inc.
Reg. No. 31-1103425United States
Innovation
1 patent family — focus: Human necessities; filing pace slowing. Cited 14 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Social engagement
Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 3 | 100% |
Recent activity
17 Jun 2026
Milestone
regulatory
8 Jun 2026
Product launch
cell therapy platform